Ledger.Open graph →

SEC Form D · Amendment · filed October 19, 2023

RS BioTherapeutics Inc

Offering

$5.0M

Sold

$1.1M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

CUMBERLAND, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Michael D. Guzman · Cumberland, MDExec H. D. Hart · Cumberland, MDExec Curtis D. Rhine · Cumberland, MDExec Justin D. Molignoni · Cumberland, MDExec · Director David D. Freas · Cumberland, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗